Other Content - BioPharm International

ADVERTISEMENT

Other Content

BioPharm International 2015 Editorial Calendar

October 1, 2014

BioPharm International 2015 Editorial Calendar

Waters - PEGylated Protein Analysis by Size-Exclusion and Reversed-Phase UPLC

September 30, 2014

Waters - PEGylated Protein Analysis by Size-Exclusion and Reversed-Phase UPLC

Eppendorf - Production of Stem Cells in Single-use Vessels

September 25, 2014

Eppendorf - Production of Stem Cells in Single-use Vessels

ProteinSimple - More Efficiency with Equivalent Data: MFI 5200

September 25, 2014

ProteinSimple - More Efficiency with Equivalent Data: MFI 5200

Acorda Acquires Biopharmaceutical Company Civitas Therapeutics

September 24, 2014

Acorda Therapeutics acquired Civitas Therapeutics for $525 million, giving Acorda all the rights to CVT-301, a Phase III candidate for off episodes of Parkinson?s disease.

Rigaku - Minimizing Excipient Fluorescence Interference Using Handheld Raman

September 23, 2014

Rigaku - Minimizing Excipient Fluorescence Interference Using Handheld Raman

GE Healthcare - Efficient, high-titer monoclonal antibody production in a fed-batch process using single-use stirred-tank and rocking bioreactor systems

September 22, 2014

GE Healthcare - Efficient, high-titer monoclonal antibody production in a fed-batch process using single-use stirred-tank and rocking bioreactor systems

BioRad - Mammalian Virus Purification Using Ceramic Hydroxyapatite

September 22, 2014

BioRad - Mammalian Virus Purification Using Ceramic Hydroxyapatite

Bayer Plans to Separate to Benefit Company Growth

September 18, 2014

Bayer separates into two entities to benefit the growth and development of Bayer Life Science and MaterialScience.

ADVERTISEMENT

ADVERTISEMENT

Click here